newsfilter
← Latest News
GlobeNewswire·

New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01

Detection of neoantigen-specific T cells directly ex vivo indicates strong EVX-01-induced immune responsesData further underlines the strong predictive performance of Evaxion’s AI-Immunology™ platformThe new biomarker